Curcumin inhibits NF-kappaB activation and reduces the severity of experimental steatohepatitis in mice.
about
Herbal medicines and nonalcoholic fatty liver diseaseCurcumin and HealthHerbal medicines for the treatment of nonalcoholic steatohepatitis: current scenario and future prospectsSignal transductions and nonalcoholic fatty liver: a mini-reviewLiver fibrosis and mechanisms of the protective action of medicinal plants targeting inflammation and the immune response.Hyperpolarized 13C Spectroscopic Evaluation of Oxidative Stress in a Rodent Model of Steatohepatitis.Curcumin inhibits hepatic protein-tyrosine phosphatase 1B and prevents hypertriglyceridemia and hepatic steatosis in fructose-fed rats.Apocynin improves insulin resistance through suppressing inflammation in high-fat diet-induced obese miceCurcumin limits the fibrogenic evolution of experimental steatohepatitis.Microbiota and nonalcoholic steatohepatitis.Proteomic analysis of mice fed methionine and choline deficient diet reveals marker proteins associated with steatohepatitis.NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications.Lack of CC chemokine ligand 2 differentially affects inflammation and fibrosis according to the genetic background in a murine model of steatohepatitis.Pharmacological targets in the treatment of abdominal aortic aneurysms.Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet.Silymarin suppresses hepatic stellate cell activation in a dietary rat model of non-alcoholic steatohepatitis: analysis of isolated hepatic stellate cells.Role of mitogen-activated protein kinases and nuclear factor-kappa B in 1,3-dichloro-2-propanol-induced hepatic injury.Murine Models of Nonalcoholic Fatty Liver Disease and Steatohepatitis.Iron overload causes oxidative stress and impaired insulin signaling in AML-12 hepatocytes.Curcumin reduces the toxic effects of iron loading in rat liver epithelial cells.Nitric oxide as a target of complementary and alternative medicines to prevent and treat inflammation and cancer.NF-kappaB signaling pathway and its therapeutic implications in human diseases.Advances in antifibrotic therapy.Pathophysiology of NASH: perspectives for a targeted treatment.Targeting oxidative stress in cancer.Treatment of non-alcoholic fatty liver disease with focus on emerging drugs.Curcumin and liver disease.Skin regenerative potentials of curcumin.Defective hepatic regeneration after partial hepatectomy in leptin-deficient mice is not rescued by exogenous leptin.Mouse models of metabolic liver injury.Natural antioxidants for non-alcoholic fatty liver disease: molecular targets and clinical perspectives.Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells.Curcumin potentiates the antitumor effects of 5-FU in treatment of esophageal squamous carcinoma cells through downregulating the activation of NF-κB signaling pathway in vitro and in vivo.Amelioration of hepatic inflammation in a mouse model of NASH using a dithiocarbamate derivative.CD18 deficiency improves liver injury in the MCD model of steatohepatitis.Celecoxib ameliorates non-alcoholic steatohepatitis in type 2 diabetic rats via suppression of the non-canonical Wnt signaling pathway expression.Combination curcumin and vitamin E treatment attenuates diet-induced steatosis in Hfe-/- mice.Curcumin and saikosaponin a inhibit chemical-induced liver inflammation and fibrosis in rats.Polyunsaturated fat in the methionine-choline-deficient diet influences hepatic inflammation but not hepatocellular injury.Quercetin treatment ameliorates inflammation and fibrosis in mice with nonalcoholic steatohepatitis.
P2860
Q26738524-DC135016-3A4D-4EBC-AC32-5C64A410ED34Q26765493-0B4E4CF0-442C-41A4-9CD6-9A517006B473Q26828615-8D0324DA-3B22-4792-B15C-661E232F55FDQ26991757-F5CEE14E-47A9-4853-A22A-79FE56C9F0D3Q30374500-09CB6F6B-EEC6-4E0E-B1DB-80FA85C6494CQ33582800-8AF04AE3-81FF-4B6A-9F25-0D239922BE1FQ34103434-E2796308-44D3-4D65-830E-AC54ABFAF423Q34595226-2397D367-57AA-43F5-97AE-BAD482F8A336Q34613675-80D74664-818D-4C1D-A419-979D86FB2BE8Q35066721-920F6641-52A2-4F9D-B864-4DCA20C40F7FQ35301810-73A46716-8444-42E2-9B26-47FC48F66B86Q35931190-241A04A1-1537-4BD4-8D43-19FACB8EF4BDQ36014318-195B849D-BF63-453E-B363-A485D04F2C1BQ36539470-83C3DAFC-D49A-4FF9-9475-2CD3FCC500CFQ36558384-0BD1B5FD-2B47-4880-8944-FE9FED5D5E40Q36613681-E910E981-EAE9-4539-9EC4-CF410716CEA3Q36754552-8C0101AD-9FAA-41F9-ABC2-C0460927FBBEQ36961972-7D52CD47-602A-4CEB-9D3C-410EEC3AB60BQ36980196-2D8FC124-248C-4644-8C3A-2B6CE2E93AA3Q37038480-CD66D80E-FD5F-4241-A357-071723B03763Q37148781-64F26FFC-E03A-4295-A715-BB5D84212189Q37293337-378E7197-0242-4850-92B5-A0815721C63CQ37353099-192CDB80-3464-46B8-90D0-BE08BAD057C7Q37699476-82C9CFB0-C27F-462A-BC39-E8DF411D3FC8Q37799839-297B3636-B98C-4947-A6A2-9F7F636BCCD9Q37847181-AB0897C9-15FE-4DF3-A121-36EFD3233079Q38072883-42CF51B0-ED73-4661-9474-6CA5A4B19D07Q38073744-6F8CABCB-1E07-4CEA-AA09-0E435BDFD79AQ38309494-BCA4BE30-2B6F-45B6-A181-20E4FBC7BED8Q38402052-587486B5-385D-4B49-83BF-0795AF89966BQ38599131-F65E3A11-0352-4259-8A3E-D5253E73EEC5Q39117420-F8F8586D-2AFE-455C-B9E0-DDC635E86254Q39270373-DFDCE12A-F55D-4FC8-A53A-8BA0A470223FQ40707212-A3C2BC44-DAF5-4277-A56D-3A9C58897839Q41617791-240E179D-8FB6-4B97-ABFA-86D33C06BCEAQ41849677-1BA10266-FA4C-422E-9AEC-83A581AC092BQ42256358-BBED5A7B-1E45-4A49-A07E-7E8EA13E2E8BQ43175847-4921DF05-E524-4841-97CC-7744186DD2D7Q44680230-2244396A-D289-41C0-9D69-02D0052E9131Q45031991-1661106E-6841-4060-9372-FDEE4FFE9B9B
P2860
Curcumin inhibits NF-kappaB activation and reduces the severity of experimental steatohepatitis in mice.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Curcumin inhibits NF-kappaB ac ...... ental steatohepatitis in mice.
@en
Curcumin inhibits NF-kappaB ac ...... ental steatohepatitis in mice.
@nl
type
label
Curcumin inhibits NF-kappaB ac ...... ental steatohepatitis in mice.
@en
Curcumin inhibits NF-kappaB ac ...... ental steatohepatitis in mice.
@nl
prefLabel
Curcumin inhibits NF-kappaB ac ...... ental steatohepatitis in mice.
@en
Curcumin inhibits NF-kappaB ac ...... ental steatohepatitis in mice.
@nl
P2093
P1476
Curcumin inhibits NF-kappaB ac ...... ental steatohepatitis in mice.
@en
P2093
Aileen dela Peña
Geoffrey C Farrell
Isabelle A Leclercq
Yves Horsmans
P304
P356
10.1016/J.JHEP.2004.08.010
P577
2004-12-01T00:00:00Z